σ2 Receptors as potential biomarkers of proliferation in breast cancer

Cancer Research

Volumn 57, Issue 1, 1997, Pages 156-161

  Mach, Robert H ^a   Smith, Cynthia R ^a   Al Nabulsi, Isaf ^a   Whirrett, Brian R ^a   Childers, Steven R ^a   Wheeler, Kenneth T ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 BIS(2 METHYLPHENYL)GUANIDINE; BIOLOGICAL MARKER; SIGMA OPIATE RECEPTOR;

ANIMAL CELL; ARTICLE; BREAST ADENOCARCINOMA; CARCINOMA CELL; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; NONHUMAN; PRIORITY JOURNAL; SCATCHARD PLOT;

ANIMALS; CELL DIVISION; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; RECEPTORS, SIGMA; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0031015053     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Kaufmann, M. Review of known prognostic variables. Recent Results Cancer Res., 140: 77-87, 1996.
2. Hayes, D. F. Serum (circulating) tumor markers for breast cancer. Recent Results Cancer Res., 140: 101-113, 1996.
3. Dressler, L. G. DNA flow cytometry measurements and their clinical relevance in node-negative breast cancer patients. Recent Results Cancer Res., 127: 61-69, 1993.
4. Bozzetti, C., Nizzoli, R., Naldi, N., Manotti, L., Savoldi, L., Camisa, R., Guazzi, A., and Cocconi, G. Fine-needle aspiration technique for the concurrent immunocytochemical evaluation of multiple biologic parameters in primary breast carcinoma. Breast Cancer Res. Treat., 32: 221-228, 1994.
5. Hedley, D. W., Clark, G. M., Cornelisse, C. J., Killander, D., Kute, T., and Merkel, D. Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast. Cytometry, 14: 482-485, 1993.
6. pot! Int. J. Radiat. Oncol. Biol. Phys., 32: 1539-1541, 1995.
7. pot). Int. J. Radiat. Oncol. Biol. Phys., 31: 833-840, 1995.
8. Hedley, D. W., Shankey, T. V., and Wheeless, L. L. DNA cytometry consensus conference. Cytometry, 14: 471, 1993.
9. Bem, W. T., Thomas, G. E., Mamone, J. Y., Homan, S. M., Levy, B. K., Johnson, F. E., and Coscia, C. J. Overexpression of σ receptors in nonneural human tumors. Cancer Res., 51: 6558-6562, 1991.
10. Vilner, B. J., John, C. S., and Bowen, W. D. Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines. Cancer Res., 55: 408-413, 1995.
11. Walker, J. M., Bowen, W. D., Walker, F. O., Matsumoto, R. R., De Costa, B., and Rice, K. R. Sigma receptors: biology and function. Pharmacol. Rev., 42: 355-402, 1990.
12. 2 receptors: characterization by ligand binding and photoaffinity labeling. Eur. J. Pharmacol. Mol. Pharmacol. Sec. 265: 9-18, 1994.
13. 125I]-N-(N-benzylpiperidin-4-yl)-4-iodobenzamide, a new σ receptor radiopharmaceutical: high affinity binding to MCF-7 breast tumor cells. J. Med. Chem., 37: 1737-1739, 1994.
14. 125I]-N-(N-benzylpiperidin-4-yl)-4-iodobenzamide: a high affinity σ receptor ligand for potential imaging of breast cancer. Cancer Res., 55: 3022-3027, 1995.
15. Wallen, C. A., Higashikubo, R., and Dethlefsen, L. A. Murine mammary tumor cells in vitro. I. The development of a quiescent state. Cell Tissue Kinet., 17: 65-77, 1984.
16. Wallen, C. A., Higashikubo, R., and Dethlefsen, L. A. Murine mammary tumor cells in vitro. II. Recruitment of quiescent cells. Cell Tissue Kinet., 17: 79-89, 1984.
17. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72: 248-254, 1976.
18. Veronesi, U. The control of breast cancer: a look into the future. Recent Results Cancer Res., 140: 1-4, 1996.
19. 18F]fluoro-2-deoxy-D-glucose. Radiology, 179: 765-770, 1991.
20. 18F]2-deoxy-D-glucose PET. Radiology, 187: 743-750, 1993.
21. Haberkorn, U., Strauss, L. G., Reisser, C., Haag, D., Dimitrakopoulou, A., Ziegler, S., Oberdorfer, F., Rudat, V., and van Kaick, G. Glucose uptake, perfusion, and cell proliferation in head and neck tumors: relation of positron emission tomography to flow cytometry. J. Nucl. Med., 32: 1548-1555, 1991.
22. Okada, J., Yoshikawa, K., Itami, M., Imaseki, K., Uno, K., Itami, J., Kuyama, J., Mikata, A., and Arimizu, N. Positron emission tomography using fluorine-18-fluorodeoxyglucose in malignant lymphoma: a comparison with proliferative activity. J. Nucl. Med., 33: 325-329, 1992.
23. Higashi, K., Clavo, A. C., and Wahl, R. L. Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and tritiated thymidine uptake. J. Nucl. Med., 34: 414-419, 1993.
24. Clavo, A. C., Brown, R. S., and Wahl, R. L. Fluorodeoxyglucose uptake in human cancer cell lines is increased by hypoxia. J. Nucl. Med., 36: 1625-1632, 1995.
25. Kubota, R., Kubota, K., Yamada, S., Tada, M., Ido, T., and Tamahashi, N. Active and passive mechanisms of [fluorine-18]fluorodeoxyglucose uptake by proliferating and prenecrotic cancer cells in vivo: a microautoradiographic study. J. Nucl. Med. 35: 1067-1075, 1994.
26. Christov, K., Chew, K. L., Ljung, B-M., Waldman, F. M., Goodson, W. H., Smith, H. S., and Mayall, B. H. Cell proliferation in hyperplastic and in situ carcinoma lesions of the breast estimated by in vivo labeling with bromodeoxyundine. J. Cell. Biochem. Suppl., 19: 165-172, 1994.
27. Shields, A. F., Lim, K., Grierson, J., Link, J., and Krohn, K. A. Utilization of labeled thymidine in DNA synthesis: studies for PET. J. Nucl. Med., 31: 337-342, 1990.
28. Miyazawa, H., Arai, T., Iio, M., and Hara, T. PET imaging of non-small-cell lung carcinoma with carbon-11-methionine: relationship between radioactivity uptake and flow-cytometric parameters. J. Nucl. Med., 34: 1886-1891, 1993.
29. 11C-methionine in breast cancer studied by PET: an association with size of S-phase fraction. Br. J. Cancer, 64: 1121-1124, 1991.
30. Jansson, T., Westlin, J. E., Ahlstrom, H., Lilja, A., Langstrom, B., and Bergh, J. Positron emission tomography studies in patients with locally advanced and/or metastatic breast cancer: a method for early therapy evaluation? J. Clin. Oncol., 13: 1470-1477, 1995.
31. Bischof Delaloye, A., and Delaloye, B. Tumor imaging with monoclonal antibodies. Semin. Nucl. Med., 25: 144-164, 1995.
32. De Jager, R., Abdel-Nabi, H., Serafini, A., Pecking, A., Klein, J. L., and Hanna, M. G., Jr. Current status of cancer immunodetection with radiolabeled human monoclonal antibodies. Semin. Nucl. Med., 23: 165-179, 1993.
33. Katzenellenbogen, J. A., Carlson, K. E., Heiman, D. F., and Goswami, R. Receptor-binding radiopharmaceuticals for imaging breast tumors: estrogen-receptor interactions and selectivity of tissue uptake of halogenated estrogen analogs. J. Nucl. Med., 21: 550-558, 1980.
34. Mintun, M. A., Welch, M. J., Siegal, B. A., Mathias, C. J., Brodack, J. W., McGuire, A. H., and Katzenellenbogen, J. A. Breast cancer: PET imaging of estrogen receptors. Radiology, 169: 45-48, 1988.
35. van Eijck, C. H., Krenning, E. P., Bootsma, A., Oei, H. Y., van Pel, R., Lindemans, J., Jeekel, J., Reubi, J. C., and Lamberts, S. W. J. Somatostatin-receptor scintigraphy in primary breast cancer. Lancet, 343: 640-643, 1994.
36. Setyono-Han, B., Henkelman, M. S., Foekens, J. A., and Klijn, J. G. M. Direct inhibitory effects of somatostatin (analogues) on the growth of human breast cancer cells. Cancer Res., 47: 1566-1570, 1987.
37. John, C. S., Vilner, B. J., Schwartz, A. M., and Bowen, W. D. Characterization of sigma receptor binding sites in human biopsied solid breast tumors. J. Nucl. Med., 37: 267P, 1996.
38. Klijn, J. G. M., Berns, P. M. J. J., van Putten, W. L. J., Bontenbal, M., Alexieva-Figusch, J., and Foekens, J. A. Critical review of growth factors as clinical tools in primary and metastatic breast cancer. Recent Results Cancer Res., 127: 77-88, 1993.
39. Brent, P. J., and Pang, G. T. σ binding site ligands inhibit cell proliferation in mammary and colon carcinoma cell lines and melanoma cells in culture. Eur. J. Pharmacol., 278: 151-160, 1995.